ALAN C SHAPIRO Insider Trading $ACTC Ocata Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ALAN C SHAPIRO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ALAN C SHAPIRO. ALAN C SHAPIRO is Director in Ocata Therapeutics, Inc. ($ACTC).
ALAN C SHAPIRO in Ocata Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ALAN C SHAPIRO: Director
Holdings: 18,833,542 shares
Latest Transaction: Oct 02 2013
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ALAN C SHAPIRO in Ocata Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 02 2013 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 555,177 | 0 | 18,833,542 | 18.3 M to 18.8 M (+3.04 %) |
| Jul 01 2013 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 543,831 | 0 | 15,594,167 | 15.1 M to 15.6 M (+3.61 %) |
| Apr 01 2013 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 525,534 | 0 | 15,050,336 | 14.5 M to 15.1 M (+3.62 %) |
| Feb 26 2013 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Option Exercise | A | 0.06 | 500,000 | 28,950 | 500,000 | |
| Jan 04 2013 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 580,348 | 0 | 14,524,802 | 13.9 M to 14.5 M (+4.16 %) |
| Oct 24 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 452,117 | 0 | 13,944,454 | 13.5 M to 13.9 M (+3.35 %) |
| Aug 02 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Option Exercise | A | 0.09 | 500,000 | 42,500 | 500,000 | |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Option Exercise | A | 0.19 | 500,000 | 95,000 | 500,000 | |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Option Exercise | A | 1.35 | 50,000 | 67,500 | 50,000 | |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Option Exercise | A | 2.48 | 50,000 | 124,000 | 50,000 | |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 509,720 | 0 | 23,488,061 | 23 M to 23.5 M (+2.22 %) |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 292,832 | 0 | 22,978,341 | 22.7 M to 23 M (+1.29 %) |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 125,000 | 0 | 22,685,529 | 22.6 M to 22.7 M (+0.55 %) |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 5,532,198 | 0 | 22,560,509 | 17 M to 22.6 M (+32.49 %) |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 13,846 | 0 | 17,028,311 | 17 M to 17 M (+0.08 %) |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 500,000 | 0 | 17,014,465 | 16.5 M to 17 M (+3.03 %) |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 100,982 | 0 | 16,514,465 | 16.4 M to 16.5 M (+0.62 %) |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 406,324 | 0 | 16,413,483 | 16 M to 16.4 M (+2.54 %) |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 554,845 | 0 | 16,007,159 | 15.5 M to 16 M (+3.59 %) |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 798,184 | 0 | 15,452,314 | 14.7 M to 15.5 M (+5.45 %) |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 683,273 | 0 | 14,654,130 | 14 M to 14.7 M (+4.89 %) |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 559,979 | 0 | 13,970,857 | 13.4 M to 14 M (+4.18 %) |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 593,662 | 0 | 13,410,878 | 12.8 M to 13.4 M (+4.63 %) |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 473,649 | 0 | 12,817,216 | 12.3 M to 12.8 M (+3.84 %) |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 584,310 | 0 | 12,343,567 | 11.8 M to 12.3 M (+4.97 %) |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 447,376 | 0 | 11,759,257 | 11.3 M to 11.8 M (+3.95 %) |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 416,229 | 0 | 11,311,881 | 10.9 M to 11.3 M (+3.82 %) |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 882,604 | 0 | 10,895,652 | 10 M to 10.9 M (+8.81 %) |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 5,000,000 | 0 | 10,013,048 | 5 M to 10 M (+99.74 %) |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 424,736 | 0 | 5,013,048 | 4.6 M to 5 M (+9.26 %) |
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Grant | A | 0.00 | 437,494 | 0 | 4,588,312 | 4.2 M to 4.6 M (+10.54 %) |
Page: 1